# CORRESP — Phio Pharmaceuticals Corp.  (PHIO)  (CIK 0001533040)

> <strong>Phio Pharmaceuticals Corp.  (PHIO)  (CIK 0001533040) → SEC staff</strong> · filed 2025-12-01 · ticker PHIO · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001683168-25-008768
- **Form:** CORRESP
- **Filer:** Phio Pharmaceuticals Corp.  (PHIO)  (CIK 0001533040)
- **CIK:** 0001533040
- **Ticker:** PHIO
- **Filed:** 2025-12-01
- **SIC industry:** 2834
- **HQ:** King of Prussia, PA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1533040/000168316825008768/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1533040&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Phio Pharmaceuticals Corp.  (PHIO)  (CIK 0001533040) (CIK 0001533040), filed 2025-12-01, accession 0001683168-25-008768. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001683168-25-008768.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*